BlackRock’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,407
Closed -$29.4K 5476
2025
Q1
$29.4K Sell
15,407
-541
-3% -$1.35K ﹤0.01% 5023
2024
Q4
$56.5K Sell
15,948
-118
-0.7% -$414 ﹤0.01% 4915
2024
Q3
$71.2K Buy
16,066
+2,824
+21% +$12.4K ﹤0.01% 4737
2024
Q2
$52.4K Buy
+13,242
New +$66.7K ﹤0.01% 4847
2023
Q1
Sell
-46
Closed -$321 5588
2022
Q4
$321 Hold
46
﹤0.01% 5685
2022
Q3
$1K Hold
46
﹤0.01% 5719
2022
Q2
$1K Sell
46
-2,278
-98% -$31.1K ﹤0.01% 5771
2022
Q1
$40K Sell
2,324
-111
-5% -$2.11K ﹤0.01% 5456
2021
Q4
$63K Buy
2,435
+62
+3% +$2.41K ﹤0.01% 5369
2021
Q3
$110K Sell
2,373
-50
-2% -$2.81K ﹤0.01% 5118
2021
Q2
$184K Sell
2,423
-20,618
-89% -$1.35M ﹤0.01% 4910
2021
Q1
$1.79M Buy
23,041
+1,003
+5% +$300K ﹤0.01% 4318
2020
Q4
$8.96M Buy
22,038
+14,632
+198% +$4.32M ﹤0.01% 3418
2020
Q3
$1.32M Buy
+7,406
New +$1.54M ﹤0.01% 4025

Other funds holding CALC

BlackRock's CALC Position: Q2 2025 in Review

BlackRock sold out of CalciMedica (CALC) in Q2 2025, closing a stake of 15,407 shares — an estimated $29.4K sold.

BlackRock first reported a position in CALC in Q3 2020 and held it in 14 quarters. The position peaked at $8.96M in Q4 2020. 30 funds tracked by Wall St. Rank hold CALC as of Q2 2025.

  • BlackRock reported no remaining CalciMedica position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 15,407 CalciMedica shares in Q2 2025, an estimated $29.4K.
  • BlackRock first reported a position in CalciMedica in Q3 2020 and held it in 14 quarters.
  • BlackRock's CalciMedica position peaked at $8.96M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.